- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Pharmaceutical Technology Europe-05-01-2010
Pharmaceutical Technology Europe
Obtaining simultaneous multiple dissolution profiles of solid oral dosage formulations
May 01, 2010
Formulation
22
5
Testing the dissolution rates of a pharmaceutical formulation (also known as in vitro availability) aids drug quality control and is a compulsory requirement of the British, European and US pharmacopoeias.
Change is in the air for the European Clinical Trials Directive
May 01, 2010
Spotlight
22
5
Though many advantages are associated with the European Clinical Trials Directive, complexities have emerged since its introduction in 2004. Since 2007, efforts have been made to raise the issues and address the negative impact of the Directive.
The possibilities and challenges of spray drying
May 01, 2010
Ask the Expert
22
5
Why spray drying processes offer a range of particle engineering possibilities.
When and why should the pharmaceutical industry use NIR chemical imaging?
May 01, 2010
Special Feature
22
5
The author assesses the power and limitations of NIR chemical imaging and its future.
Change management: common failures and a checklist for improvement
May 01, 2010
Regulation
22
5
Though the pharma industry has improved its change management processes, there are still opportunities for improvement.
Bioanalysis: hurdles and hopes
May 01, 2010
Special Feature
22
5
Bioanalysis has migrated from a very general vocation to one that requires more specialization, particularly in GLP applications.
Innovations in dissolution testing
May 01, 2010
Special Feature
22
5
Advances in dissolution testing technology have been one of the biggest breakthroughs in solid dosage form testing over the last decade.
Understanding powder behaviour
May 01, 2010
Special Feature
22
5
The needs of the pharmaceutical industry for powder testing technologies are changing, primarily for two reasons.
What do you think?
May 01, 2010
22
5
Over the last few months, we have been publishing a series of special features, which have sought to provide you with an overall view of current challenges, innovations and trends in niche pockets of the pharmaceutical industry.
Do emerging markets provide the answer to the pharmaceutical industry?
May 01, 2010
Manufacturing
22
5
The emerging markets represent an attractive investment opportunity for the pharmaceutical industry because of the countries' growing economies and unmet medical needs.
The Lilly Way
May 01, 2010
Outsourcing Review
22
5
Lilly faces up to the new realities of the bio/pharmaceutical industry by embracing outsourcing.
REACH: has the cloud of confusion cleared?
May 01, 2010
Manufacturing
22
5
The pharmaceutical industry must understand its responsibilities to improve the safety of chemicals as defined by the REACH initiative.